Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease

被引:28
作者
Carey, EJ
Douglas, DD
机构
[1] Mayo Clin Hosp, Div Transplantat Med, Phoenix, AZ 85054 USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Scottsdale, AZ USA
关键词
autonomic dysfunction; end-stage liver disease; QT interval;
D O I
10.1007/s10620-005-1603-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Autonomic dysfunction is a recognized complication of end-stage liver disease (ESLD) associated with a poor prognosis. The corrected QT interval (QTc) on electrocardiogram is a marker of autonomic function. A few small studies have suggested that QTc may normalize with the return of liver function after orthotopic liver transplantation. We sought to determine how transplantation affects the QTc in patients with ESLD. The QTc from the pretransplantation evaluation of 46 patients with ESLD was compared with the QTc at 4-month posttransplantation follow-up. Other factors that can influence autonomic function also were evaluated. Most patients with ESLD (54%) showed a prolonged QTc (greater than or equal to 440 msec) at the pretransplantation evaluation ( 451 +/- 45 msec) that improved to within the normal range at posttransplantation follow-up ( 418 +/- 18 msec; P < 0.001). There was no relationship between QTc prolongation and Child - Turcotte - Pugh score, Model for End-Stage Liver Disease score, diabetes mellitus, age, or etiology of liver disease. Most patients with ESLD and a prolonged QTc will have a significant improvement in QTc after transplantation; however, 6.5% of patients in our study had a worsening of QTc after transplantation.
引用
收藏
页码:320 / 323
页数:4
相关论文
共 19 条
[1]   Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation [J].
Bal, JS ;
Thuluvath, PJ .
LIVER INTERNATIONAL, 2003, 23 (04) :243-248
[2]   Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors [J].
Bernardi, M ;
Calandra, S ;
Colantoni, A ;
Trevisani, F ;
Raimondo, ML ;
Sica, G ;
Schepis, F ;
Mandini, M ;
Simoni, P ;
Contin, M ;
Raimondo, G .
HEPATOLOGY, 1998, 27 (01) :28-34
[3]  
Finucci G, 1998, JPN HEART J, V39, P321
[4]  
Fleckenstein JF, 1996, HEPATOLOGY, V23, P471
[5]   Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation [J].
González, MG ;
Hernandez-Madrid, A ;
Lopez-Sanromán, A ;
Candela, A ;
Nuño, J ;
Barcena, R .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) :2366-2367
[6]   NATURAL-HISTORY OF AUTONOMIC NEUROPATHY IN CHRONIC LIVER-DISEASE [J].
HENDRICKSE, MT ;
THULUVATH, PJ ;
TRIGER, DR .
LANCET, 1992, 339 (8807) :1462-1464
[7]   PERIPHERAL AND CARDIOVASCULAR AUTONOMIC IMPAIRMENT IN CHRONIC LIVER-DISEASE - PREVALENCE AND RELATION TO HEPATIC-FUNCTION [J].
HENDRICKSE, MT ;
TRIGER, DR .
JOURNAL OF HEPATOLOGY, 1992, 16 (1-2) :177-183
[8]   QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration - A case report [J].
Hodak, SP ;
Moubarak, JB ;
Rodriguez, I ;
Gelfand, MC ;
Alijani, MR ;
Tracy, CM .
TRANSPLANTATION, 1998, 66 (04) :535-537
[9]   QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506 [J].
JOHNSON, MC ;
SO, S ;
MARSH, JW ;
MURPHY, AM .
TRANSPLANTATION, 1992, 53 (04) :929-930
[10]   Probable case of Torsades de Pointes induced by fluconazole [J].
Khazan, M ;
Mathis, AS .
PHARMACOTHERAPY, 2002, 22 (12) :1632-1637